Status:

COMPLETED

Safety And Efficacy Study Of Depakote ER To Treat Pediatric Bipolar Disorder

Lead Sponsor:

Medical College of Wisconsin

Conditions:

Bipolar Disorder

Eligibility:

All Genders

6-17 years

Phase:

PHASE4

Brief Summary

The purpose of this research is to compare how safely and how well this medicine works in treating children and teenagers between the ages of 6 and 17 years with a diagnosis of Bipolar Disorder.

Detailed Description

There is no accepted, well-studied treatment for Pediatric Bipolar Disorder and treatment has often followed from adult studies. The primary objectives for this study are to determine if subjects can ...

Eligibility Criteria

Inclusion

  • Diagnosis of Bipolar I or II confirmed by K-SADS and clinical interview.
  • Ages 6 to 17 years 11 months.
  • YMRS score of \<10, this is consistent with minimal symptoms of mania. Or a desire to change medications due to a simplified dosing schedule or to reduce unwanted side effects of divalproex sodium.
  • Ability and willingness of subject and parent(s)/guardian(s) to provide informed written assent/consent.

Exclusion

  • Diagnosis of: Pervasive Developmental Disorders, Schizophrenia spectrum disorders, Obsessive Compulsive Disorder.
  • Concurrent medical conditions requiring medication or that are unstable.
  • Current suicidal thoughts.
  • Recent suicidal behavior.
  • Pregnancy or sexually active female not using a reliable form of contraception.
  • Previous inadequate response to DVP ER.
  • Known hypersensitivity to DVP or DVP ER.
  • Recent inpatient hospitalization for suicidality or homicidality, (last 6 months).
  • Subjects who are clinically stable and not suffering significant side effects on their current medical regimen.
  • Use of antidepressants within the last 2 weeks, 4 weeks for fluoxetine.
  • Recent (last 3 months) substance abuse or dependence. Urine drug screen will be obtained if a question arises.

Key Trial Info

Start Date :

December 1 2003

Trial Type :

INTERVENTIONAL

End Date :

November 1 2005

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT00199966

Start Date

December 1 2003

End Date

November 1 2005

Last Update

March 7 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Children's Hospital of Wisconsin

Milwaukee, Wisconsin, United States, 53201